Lessons in Persistence: New Long COVID Trials AIm To Clear LIngering Virus

Long COVID has been a vexing foe, but these clinical trials mark a new chapter. They’re the first targeting the syndrome’s underlying biology, including the one Hayden joined, focus on a key question: Is lingering SARS-CoV-2 virus behind patients’ symptoms?